Helixgate

Helixgate

Uncategorized

Sidewinder secures $137M to advance ‘precision’ ADCs

Published

on

Backed by OrbiMed, Novartis’ venture arm and many other investors, the biotech is among those working on newer technology that could broaden the reach of antibody-drug conjugates.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Uncategorized

What actually drives speed in complex drug development programs

Learn how early coordination across functions, phases and partners can reduce risk and accelerate drug development.

Read More

Published

on

Learn how early coordination across functions, phases and partners can reduce risk and accelerate drug development.

Read More

Continue Reading

Uncategorized

From Product to Patient in Nuclear Medicine: Why Vertical Integration Is Essential for a Competitive Advantage

From Product to Patient in Nuclear Medicine: Why Vertical Integration Is Essential for a Competitive Advantage

Published

on

In nuclear medicine, innovation alone isn’t enough. What matters is whether it can be delivered on time, every time, because timing is critical for our patients. And that delivery promise must hold up under real-world pressure – from routine variability to sudden disruptions that can reroute global logistics overnight.​ ​Read More

Continue Reading

Uncategorized

KRAS drugmakers take another, better swing at lung cancer

Published

on

SAN DIEGO — In early cuts of data, the next iteration of KRAS drugs for lung cancer appears to bear more promise than the first.

KRAS mutations drive around a quarter of all cancer cases and …

Continue Reading
Advertisement

Trending